These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31647157)

  • 1. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Staff NP; Cavaletti G; Islam B; Lustberg M; Psimaras D; Tamburin S
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2(Suppl 2):S26-S39. PubMed ID: 31647151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.
    Schneider BP; Zhao F; Ballinger TJ; Garcia SF; Shen F; Virani S; Cella D; Bales C; Jiang G; Hayes L; Miller N; Srinivasiah J; Stringer-Reasor EM; Chitalia A; Davis AA; Makower DF; Incorvati J; Simon MA; Mitchell EP; DeMichele A; Miller KD; Sparano JA; Wagner LI; Wolff AC
    J Clin Oncol; 2024 Aug; 42(24):2899-2907. PubMed ID: 38828938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
    Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
    Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of a Complementary/Integrative Medicine Treatment Program on Taxane-Induced Peripheral Neuropathy: A Brief Report.
    Ben-Arye E; River Y; Keshet Y; Lavie O; Israeli P; Samuels N
    Int J Gynecol Cancer; 2018 Jun; 28(5):1045-1049. PubMed ID: 29561303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
    Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
    Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS).
    Williams LA; Garcia-Gonzalez A; Mendoza TR; Haq S; Cleeland CS
    Support Care Cancer; 2019 Mar; 27(3):1021-1028. PubMed ID: 30094731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
    Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
    J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
    Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
    Andersen Hammond E; Pitz M; Shay B
    Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
    Taxane-related Peripheral Neuropathy Standardized Management Group
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
    Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
    Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
    Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy.
    Hertz DL
    Curr Opin Support Palliat Care; 2024 Mar; 18(1):30-38. PubMed ID: 38126251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case-control study.
    Kus T; Aktas G; Alpak G; Kalender ME; Sevinc A; Kul S; Temizer M; Camci C
    Support Care Cancer; 2016 May; 24(5):2085-2091. PubMed ID: 26546457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epothilone-induced peripheral neuropathy: a review of current knowledge.
    Argyriou AA; Marmiroli P; Cavaletti G; Kalofonos HP
    J Pain Symptom Manage; 2011 Dec; 42(6):931-40. PubMed ID: 21621965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
    Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
    Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral nerve damage associated with administration of taxanes in patients with cancer.
    Argyriou AA; Koltzenburg M; Polychronopoulos P; Papapetropoulos S; Kalofonos HP
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):218-28. PubMed ID: 18329278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral neuropathy induced by microtubule-stabilizing agents.
    Lee JJ; Swain SM
    J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.